Kieuhoa Vo

Circulating Biomarkers of Clinical Response to Combination Targeted Therapies in Neuroblastoma

National Cancer Institute · R01

Contact PI · $1.6M · University of California, San Francisco

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

Principal investigator · Not yet recruiting · Phase 1, Phase 2

National Cancer Institute (NCI)

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Principal investigator · Active not recruiting · Phase 1

Valent Technologies, LLC

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Principal investigator · Active not recruiting · Phase 2

National Cancer Institute (NCI)

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

Principal investigator · Completed · Phase 1

University of California, San Francisco